Paragon Care Limited (PXS) - Total Assets
Based on the latest financial reports, Paragon Care Limited (PXS) holds total assets worth €1.75 Billion EUR (≈ $2.05 Billion USD) as of June 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Paragon Care Limited for net asset value and shareholders' equity analysis.
Paragon Care Limited - Total Assets Trend (2014–2024)
This chart illustrates how Paragon Care Limited's total assets have evolved over time, based on quarterly financial data.
Paragon Care Limited - Asset Composition Analysis
Current Asset Composition (June 2024)
Paragon Care Limited's total assets of €1.75 Billion consist of 60.0% current assets and 40.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 1.8% |
| Accounts Receivable | €350.58 Million | 31.0% |
| Inventory | €270.24 Million | 23.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €26.36 Million | 2.3% |
| Goodwill | €323.12 Million | 28.6% |
Asset Composition Trend (2014–2024)
This chart illustrates how Paragon Care Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Paragon Care Limited stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Paragon Care Limited's current assets represent 60.0% of total assets in 2024, an increase from 44.4% in 2014.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2024, down from 10.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, a decrease from 50.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 31.0% of total assets.
Paragon Care Limited Competitors by Total Assets
Key competitors of Paragon Care Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Paragon Care Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.22 | 1.42 | 1.89 |
| Quick Ratio | 0.53 | 0.74 | 1.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €186.48 Million | €39.10 Million | €65.06 Million |
Paragon Care Limited - Advanced Valuation Insights
This section examines the relationship between Paragon Care Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.39 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 152.1% |
| Total Assets | €1.13 Billion |
| Market Capitalization | $152.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values Paragon Care Limited's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Paragon Care Limited's assets grew by 152.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Paragon Care Limited (2014–2024)
The table below shows the annual total assets of Paragon Care Limited from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | €1.13 Billion ≈ $1.32 Billion |
+152.14% |
| 2023-06-30 | €448.52 Million ≈ $524.37 Million |
+2.63% |
| 2022-06-30 | €437.03 Million ≈ $510.93 Million |
+49.71% |
| 2021-06-30 | €291.92 Million ≈ $341.29 Million |
-0.09% |
| 2020-06-30 | €292.17 Million ≈ $341.58 Million |
-23.95% |
| 2019-06-30 | €384.20 Million ≈ $449.17 Million |
+9.85% |
| 2018-06-30 | €349.75 Million ≈ $408.89 Million |
+110.62% |
| 2017-06-30 | €166.05 Million ≈ $194.13 Million |
+12.36% |
| 2016-06-30 | €147.79 Million ≈ $172.78 Million |
+264.14% |
| 2015-06-30 | €40.59 Million ≈ $47.45 Million |
+50.59% |
| 2014-06-30 | €26.95 Million ≈ $31.51 Million |
-- |
About Paragon Care Limited
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provi… Read more